Growth Metrics

Ceribell (CBLL) Return on Equity (2024 - 2026)

Ceribell posted quarterly Return on Equity of 0.0% for Q1 2026, little changed year-on-year from 0.0% in Q1 2025, and down 21.91% on a QoQ basis from 0.0% in Q4 2025.

Ceribell (CBLL) has 3 years of Return on Equity data on file, last reported at 0.0% in Q1 2026.

  • For the quarter ending Q1 2026, Return on Equity changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, up 1.0% from the prior year.
  • Return on Equity for Q1 2026 stood at 0.0%, down from 0.0% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.0% in Q3 2024 and bottomed at 0.01% in Q4 2024.
  • The 3-year median for Return on Equity is 0.0% (2025), against an average of 0.0%.
  • Peak annual rise in Return on Equity reached 1 bps in 2025, while the deepest fall reached 1 bps in 2025.
  • A 3-year view of Return on Equity shows it stood at 0.01% in 2024, then jumped by 77 bps to 0.0% in 2025, then dropped by 22 bps to 0.0% in 2026.
  • The last three Return on Equity figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.00%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.00%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.00%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.00%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.00%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.00%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Ceribell 666.26 Mn 525.07 Mn 23.12 Mn 0.00%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 0.00%
Sep 30, 2025 0.00%
Jun 30, 2025 0.00%
Mar 31, 2025 0.00%
Dec 31, 2024 -0.01%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%